Literature DB >> 25211552

Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.

Stefanie Hoyer1, Sabrina Prommersberger, Isabell A Pfeiffer, Beatrice Schuler-Thurner, Gerold Schuler, Jan Dörrie, Niels Schaft.   

Abstract

T-cell help is essential for CTL-memory formation. Nevertheless, it is unclear whether the continuous presence of CD4(+) T-helper (Th) cells is required during dendritic cell (DC)/CD8(+) T-cell encounters, or whether a DC will remember the helper signal after the Th cell has departed. This question is relevant for the design of therapeutic cancer vaccines. Therefore, we investigated how human DCs need to interact with CD4(+) T cells to mediate efficient repetitive CTL expansion in vitro. We established an autologous antigen-specific in vitro system with monocyte-derived DCs, as these are primarily used for cancer vaccination. Contrary to common belief, a sequential interaction of licensed DCs with CD8(+) T cells barely improved CTL expansion. In sharp contrast, simultaneous encounter of Th cells and CTLs with the same DC during the first in vitro encounter is a prerequisite for optimal subsequent CTL expansion in our in vitro system. These data suggest that, in contrast to DC maturation, the activation of DCs by Th cells, which is necessary for optimal CTL stimulation, is transient. This knowledge has significant implications for the design of new and more effective DC-based vaccination strategies. Furthermore, our in vitro system could be a valuable tool for preclinical immunotherapeutical studies.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CTL expansion; Dendritic cells; T-cell help; Three-cell interaction; Two-cell interaction

Mesh:

Substances:

Year:  2014        PMID: 25211552     DOI: 10.1002/eji.201444477

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.

Authors:  Stefanie Gross; Michael Erdmann; Ina Haendle; Steve Voland; Thomas Berger; Erwin Schultz; Erwin Strasser; Peter Dankerl; Rolf Janka; Stefan Schliep; Lucie Heinzerling; Karl Sotlar; Pierre Coulie; Gerold Schuler; Beatrice Schuler-Thurner
Journal:  JCI Insight       Date:  2017-04-20

Review 2.  Therapeutic cancer vaccines.

Authors:  Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

Review 3.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

4.  An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs.

Authors:  Masatoshi Hirayama; Yusuke Tomita; Akira Yuno; Hirotake Tsukamoto; Satoru Senju; Yuya Imamura; Mohammad Abu Sayem; Atsushi Irie; Yoshihiro Yoshitake; Daiki Fukuma; Masanori Shinohara; Akinobu Hamada; Hirofumi Jono; Eiji Yuba; Kenji Kono; Koji Yoshida; Takuya Tsunoda; Hideki Nakayama; Yasuharu Nishimura
Journal:  Oncoimmunology       Date:  2016-01-04       Impact factor: 8.110

5.  Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.

Authors:  Kerstin F Gerer; Michael Erdmann; Sine R Hadrup; Rikke Lyngaa; Lena-Marie Martin; Reinhard E Voll; Beatrice Schuler-Thurner; Gerold Schuler; Niels Schaft; Stefanie Hoyer; Jan Dörrie
Journal:  Ther Adv Med Oncol       Date:  2017-06-13       Impact factor: 8.168

Review 6.  Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.

Authors:  S K Daniel; K M Sullivan; K P Labadie; V G Pillarisetty
Journal:  Clin Transl Med       Date:  2019-04-01

7.  NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells.

Authors:  Naomi C Bosch; Reinhard E Voll; Caroline J Voskens; Stefanie Gross; Barbara Seliger; Gerold Schuler; Niels Schaft; Jan Dörrie
Journal:  Ther Adv Med Oncol       Date:  2019-12-11       Impact factor: 8.168

8.  Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.

Authors:  Qingjiang Hu; Kentaro Nonaka; Hiroaki Wakiyama; Yu Miyashita; Yoshiaki Fujimoto; Tomoko Jogo; Kentaro Hokonohara; Ryota Nakanishi; Yuichi Hisamatsu; Koji Ando; Yasue Kimura; Takaaki Masuda; Eiji Oki; Koshi Mimori; Yoshinao Oda; Masaki Mori
Journal:  Cancer Med       Date:  2021-03-26       Impact factor: 4.452

9.  Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.

Authors:  Jan Dörrie; Christian Krug; Christian Hofmann; Ina Müller; Verena Wellner; Ilka Knippertz; Stephan Schierer; Simone Thomas; Elke Zipperer; Dieter Printz; Gerhard Fritsch; Gerold Schuler; Niels Schaft; Rene Geyeregger
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.

Authors:  Han-Ning Li; Xing-Rui Li; Zheng-Tao Lv; Miao-Miao Cai; Ge Wang; Zhi-Fang Yang
Journal:  Cancer Med       Date:  2020-10-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.